Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SCIENCE GROUP PLC Capital/Financing Update 2019

Feb 20, 2019

7903_rns_2019-02-20_da85f053-0bc8-4d9a-86af-6debd34619e8.html

Capital/Financing Update

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5371Q

Science Group PLC

20 February 2019

20 February 2019

Science Group plc

("Science Group" or "Group" or "Company")

Extended Bank Facilities

As outlined in the announcement dated 24 January 2019 related to the corporate strategic review, the Group has now finalised the extension of the bank loan, increasing the debt from £12.75 million at 31 December 2018 to £17.5 million.

The repayment date of the additional £4.75 million is the same as the current loan, September 2026. An additional interest rate swap has been taken to fix the effective interest rate of the incremental debt at 4.0%. This is 0.5% above the rate fixed via similar swap instruments in 2016 which remain in place at an effective rate for the £12.75 million of 3.5%.

The other terms and conditions of the incremental loan are the same as the original facility as set out in the announcement on 16 September 2016.

For further information:

Science Group plc

Martyn Ratcliffe, Chairman
Tel: +44 (0) 1223 875200
Panmure Gordon (UK) Limited
Dominic Morley/Alina Vaskina (Corporate Finance)

Erik Anderson (Corporate Broking)
Tel: +44 (0) 20 7886 2500

The information communicated in this announcement is inside information for the purposes of Article 7 of the Market Abuse Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCUKURRKBAUAUR